Chief Scientific Officer
hC Bioscience, Inc.
Boston, United States
Jose Lora is Chief Scientific Officer at hC Bioscience, a biotechnology company focused on the development of engineered tRNA for therapeutic applications. Prior to hC Bioscience, he served as CSO at Intergalactic Therapeutics, a non-viral gene therapy company with a major emphasis on Ophthalmology. Previous to Intergalactic, Jose was CSO at enGene, a clinical-stage non-viral gene therapy company focused on gene delivery to mucosal surfaces for immuno-oncology applications. Before enGene, Jose served in multiple roles at several biotechnology and pharmaceutical companies developing synthetic biology and epigenetics platforms for immunology, oncology and rare diseases. Throughout his career, Jose has been responsible for the transition of multiple programs from research to clinical development.
Jose received his PhD from the University of Seville, Spain, and was a postdoctoral researcher at Brown University and The University of Utah, in the US. He has authored numerous patent applications, as well as peer-reviewed articles in high-impact journals.